Sickle Cell Disease and Bone Marrow Transplant in Ethiopia

A genetic blood condition called sickle-cell disease damages the hemoglobin in red blood cells. Sickle cell disease (SCD), which can affect up to 3% of births nationwide, is widespread throughout Ethiopia. Nevertheless, many health ministries continue to place little importance on it, but now the government is taking initiatives to tackle the diseases. However, SCD has a variety of negative impacts, including increased morbidity and mortality, a decline in quality of life, and a significant socioeconomic burden on individuals, families, and healthcare systems. This post will tell you about Sickle Cell Disease in Ethiopia and how it is treated with a bone marrow transplant.

According to experts, the number of Sickle cell disease patients will rise over the following several decades. Health outcomes for those with SCD have significantly improved in Ethiopia. But for many patients, Sickle cell disease problems reduce opportunities and degrade their quality of life. The lives of those who have Sickle cell disease can be improved by increasing access to care and lowering treatment expenses. In addition, bone marrow transplant facilities should be provided quickly in the country as the chance of getting cured of Sickle cell disease is more by BMT.

Bone Marrow Transplant cost for Sickle Cell Disease in Ethiopia

The cost of BMT for Sickle Cell Disease in Ethiopia is around $40,000. Therefore, the price in Ethiopia is very affordable compared to a developed country.

Initiatives by the Ethiopian Government for Sickle Cell Disease Awareness

Hydroxyurea improves Sickle Cell Disease results and lowers healthcare costs. However, it is ineffective for more than 75% of adults with SCD who have recurrent pain crises.

About 30% of neonates do not receive follow-up care after their diagnosis. However, the government is reaching them for regular checkups and following up on recovery conditions.

People with SCD who seek emergency care face lengthier wait times due to discrimination and a lack of qualified specialists, despite having higher levels of discomfort. But now, due to different schemes and facilities by the health ministry of Ethiopia, patients are getting faster treatment, and qualified doctors are treating the patients to achieve a successful result.

Earlier, Pneumococcal immunization was not given to 25% of children with SCD. But due to medical camps and awareness, the children are screened and appropriately immunized.

Transitioning from childhood to adult care is the most dangerous time for hospitalizations and medical problems. However, adequately facilitated hospitals are built, and qualified surgeons and staff manage the situation.

Ethiopia Government Objectives for Sickle Cell Disease Treatment

To ensure effective disease management and avert a crisis, strategies are developed to focus on prevention and early diagnosis.

The Sickle Cell Disease Control Program strongly emphasizes patient counseling, treatment, and early disease diagnosis.

Adolescents, pregnant women, and new mothers are the primary target populations for screening. Unfortunately, the only way to prevent this illness is through prevention because it is hereditary and has no known treatment.

FAQs on Sickle Cell Disease Treatment and Bone Marrow Transplant in Ethiopia